But Millar said the new patient population will be "the next opportunity for a jump ball" between Novo's and Lilly's medications
Marcin S, Lene T, Richard JW, Marina B, Peter VB, George AWB, Emilio F, Frederique G, Annamaria I, Peter M, Ingrid M, Esperanza N, Wolfgang ASandMaria, Antonietta D
Multiple studies have highlighted the glycemic, weight, and cardiac benefits of semaglutide, a glucagon-like peptide-1 receptor agonist (GLP1-RA), treatment in patients with or without type 2 diabetes (T2D)
The interest in GLP-1 medications for Hashimoto's patients often stems from their metabolic effects rather than direct thyroid benefits
GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists: strengthened warnings on acute pancreatitis
Injection technique is identical for both medications: subcutaneous injection into the abdomen, thigh, or upper arm